Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

Novo Nordisk · Phase 3 · Status n/r · Enrollment 370

NCT06633783

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide injectionn/rn/rn/rn/rn/r
Wegovy®n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.